BCRX vs INTC Stock Comparison

BCRX currently leads INTC in this stock comparison, with AIQ scores of 59 vs 36. The clearest difference is value.

Market data as of Nov 15, 2026 market close· AIQ score gap 23 points
BCRX
Healthcare
vs
INTC
Technology
BCRX
BioCryst Pharmaceuticals, Inc.
Leads
Price
$7.61
Day move
-0.91%
AIQ Score
59/100
Best edge
Value
Sector
Healthcare
INTC
Intel Corp.
Price
$59.66
Day move
-2.52%
AIQ Score
36/100
Best edge
Balanced
Sector
Technology

What is the main difference between BCRX and INTC?

BCRX leads the current stock comparison as BioCryst Pharmaceuticals, Inc., with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

BioCryst Pharmaceuticals, Inc. vs Intel Corp.

Data as of Nov 15, 2026· market close· Cross-sector · Healthcare vs Technology· Coverage 65/66 fields· High confidence
AIQ VerdictStableAIQ Comparison Conviction 9/10

BCRX leads

BCRX leads by 23 AIQ points, primarily on Value and Quality, and the lead has widened from 8 points over 30 sessions. Wall Street currently favors INTC on target upside.

Stable: 4 of 6 evidence groups support BCRX, and its lead is widening.

Evidence agreement: 4 of 6Comparison trend: Strengthening
BCRX

BioCryst Pharmaceuticals, Inc.

Leads
AIQ Score
59/100
AIQ Edge Score
6/10
INTC

Intel Corp.

AIQ Score
36/100
AIQ Edge Score
2/10

The Algovestiq AIQ Score currently favors BCRX over INTC, 59 versus 36 as of Nov 15, 2026. BCRX's advantage is driven primarily by stronger value and quality. BCRX also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors INTC. 4 of 6 covered evidence groups favor BCRX today, and the comparison is rated Stable on stability: the lead has swung materially session to session. BCRX lead: Strengthening — the AIQ differential moved from 8 to 23 points over 30 sessions. BCRX leads on all four AIQ factor dimensions. Value is itself one of those four, so a sweep is not explained by valuation alone — it deserves additional scrutiny for unmodeled catalysts, expectations or event risk.

Compare BioCryst Pharmaceuticals, Inc. and Intel Corp. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

BCRX
-36.6%
INTC
+28.1%

Total return comparison

Growth of $10,000, distributions reinvested

BCRX $6,336 · INTC $12,812

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare BCRX and INTC against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

BCRX advantage
0
INTC advantage
  • Value86 vs 47
    BCRX +39
  • Quality64 vs 38
    BCRX +26
  • Risk Resilience55 vs 29
    BCRX +26
  • Momentum42 vs 30
    BCRX +12

4 of 6 evidence groups favor BCRX. BCRX’s edge is concentrated in value and quality.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

BCRX0 AIQ

Largest factor move: Quality +1, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 4 active signals are unchanged.

INTC0 AIQ

Largest factor move: Quality -1, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 5 active signals are unchanged.

BCRX's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — BCRX and INTC both carry a full feed there.

The central trade-off

BCRX (BioCryst Pharmaceuticals, Inc.): the stronger current systematic profile, led by value and quality.

INTC (Intel Corp.): the counter-case, on fundamentals, analyst expectations — but at materially higher volatility, 128.4% against 45.2%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

BCRX

BCRX on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

INTC

INTC on combined revenue and EPS growth.

Value

BCRX

BCRX on the peer-relative Value factor, by 39 points.

Momentum

BCRX

BCRX on the Momentum factor, by 12 points.

Lower downside

BCRX

BCRX on Risk Resilience, by 26 points.

Analyst upside

INTC

INTC on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors BCRX, analyst targets favor INTC. That disagreement is the most useful thing on this page.

MeasureBCRXINTCNote
Implied upside to target+44.5%+75.8%INTC has more room
Target dispersion0%+71.5%Lower is tighter analyst agreement
ConsensusBuyHoldContext, not a primary driver
Analysts covering1151Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 6 covered evidence groups favor BCRX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreBCRX59 vs 36
FundamentalsINTCrevenue growth -17.4% vs 2.4%; EPS growth -51.6% vs 129.2%; TTM ROE -9.5% vs 2.9%; gross margin 25.3% vs 40.2%; operating margin -30.1% vs 3.2%
ValuationBCRXValue 86 vs 47
TechnicalsBCRXPrice vs 50-day -7.6% vs -37.2%; vs 200-day -13.5% vs -31.7%
Risk ResilienceBCRXRisk Resilience 55 vs 29
Analyst expectationsINTCTarget upside 44.5% vs 75.8%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BCRX and INTC and are excluded from the count.

AIQ Decision Stability

Stable

The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.

  • The AIQ gap is wide at 23 points. (supports the conclusion holding)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The lead has swung materially session to session. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BCRX.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

BCRX lead: Strengthening — the AIQ differential moved from 8 to 23 points over 30 sessions.

May 27BCRX leads above the line · INTC leads belowNov 13
Today
BCRX +23
59 vs 36
7 sessions ago
BCRX +26
62 vs 36
30 sessions ago
BCRX +8
60 vs 52
90 sessions ago
BCRX +21
71 vs 50

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

BCRX

0 bullish / 2 bearish / 2 neutral

Only BCRX

  • Death Cross Active — bearish, trend, long horizon (6.91%)
  • ADX Trend Weakening — neutral, trend, medium horizon
  • Downtrend Structure Active — bearish, trend, long horizon
INTCConflicted

1 bullish / 2 bearish / 2 neutral, conflicted

Only INTC

  • Golden Cross Active — bullish, trend, long horizon (8.67%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • Keltner Channel Breakdown — bearish, volatility, short horizon

Both carry 1 more signal that do not separate them: ATR Expansion - Breakout Mode.

INTC is conflicted, so the timing case there is weaker than the score alone suggests.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

BCRXNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.91%, AIQ 0 points).

INTCNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.52%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1INTC closes the Value gap — currently 39 points behind, the largest single contributor to BCRX's edge.
  2. 2INTC's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
  3. 3BCRX starts generating bearish momentum or trend signals.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

INTC leads on balance
MetricBCRXINTC
Revenue growth (YoY)-17.4%2.4%
EPS growth (YoY)-51.6%129.2%
Gross margin25.3%40.2%
Operating margin-30.1%3.2%
Return on equity (TTM)-9.5%2.9%
Debt to equity-2.080.44

Performance

Split across windows
MetricBCRXINTC
1 week (5 sessions)-1%6%
1 month (20 sessions)-2.3%-33.6%
3 months (63 sessions)-23.4%-42.4%
6 months (126 sessions)-15.6%-45.2%
Year to date-2.4%61.7%
1 year (252 sessions)6%57.5%

Technicals

BCRX has the stronger structure
MetricBCRXINTC
RSI (14)40.732.4
ADX (14)15.241
Price vs 50-day-7.6%-37.2%
Price vs 200-day-13.5%-31.7%
Volatility (1M, annualized)45.2%128.4%

Risk

BCRX is the more resilient
MetricBCRXINTC
Beta0.653.21
Sharpe ratio0.360.98
Sortino ratio0.561.49
Max drawdown-32.2%-62.9%
Current drawdown-31.5%-57.7%
Annualized volatility48.1%84.7%
Value at risk (95%)-4.1%-6.6%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, BCRX or INTC?

On the Algovestiq AIQ Score, BCRX is the stronger of the two as of Nov 15, 2026, scoring 59 against INTC's 36. The edge comes from value and quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is BCRX or INTC the better buy right now?

BCRX carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 4 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.

Why does the AIQ Score favor BCRX over INTC?

The composite weights Quality, Value, Momentum and Risk Resilience. BCRX leads Value by 39 points; BCRX leads Quality by 26 points; BCRX leads Risk Resilience by 26 points. BCRX leads on all four AIQ factor dimensions. Value is itself one of those four, so the sweep is not explained by INTC simply being cheaper — it warrants extra scrutiny for unmodeled catalysts, forward expectations or event risk the factors do not capture.

Which has more analyst upside, BCRX or INTC?

Analyst price targets imply +44.5% upside for BCRX and +75.8% for INTC, so the Street currently favors INTC. That points the opposite way to the AIQ Score, which favors BCRX. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, BCRX or INTC?

BCRX is the better-valued of the two on the peer-relative Value factor. BCRX on the peer-relative Value factor, by 39 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, BCRX or INTC?

INTC on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, BCRX or INTC?

BCRX on the Momentum factor, by 12 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, BCRX or INTC?

BCRX is the more resilient of the two, so the other name carries the higher downside risk. BCRX on Risk Resilience, by 26 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is BCRX more profitable than INTC?

INTC leads on the comparable margin measures — gross margin 25.3% vs 40.2%; operating margin -30.1% vs 3.2%; ttm roe -9.5% vs 2.9%.

Is BCRX's lead over INTC getting stronger or weaker?

BCRX lead: Strengthening — the AIQ differential moved from 8 to 23 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the BCRX vs INTC verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: INTC closes the Value gap — currently 39 points behind, the largest single contributor to BCRX's edge; INTC's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; BCRX starts generating bearish momentum or trend signals; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about BCRX and INTC?

BCRX: 0 bullish / 2 bearish / 2 neutral. INTC: 1 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BCRX is Death Cross Active (bearish, long horizon). On INTC it is Golden Cross Active (bullish, long horizon).

Compare BCRX and INTC with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.